VI004 - Shingles vaccination

VI004 - Shingles vaccination

The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF).                                                                     

Indicator definition

Indicator ID

Description

VI004

The percentage of patients who reached 80 years old in the preceding 12 months, who have received a shingles vaccine between the ages of 70 and 79 years.

What do the business rules mean?

What makes a patient eligible?

Patients are eligible for the VI004 denominator if they turned 80 years old in the contract year or 81 years old if they had received only one dose of Shingrix before the age of 80 (and before the start of the contract year)

How to achieve the indicator

To meet the criteria for VI004, eligible patients must have had either:
  1. a ‘single dose’ shingles vaccination (Zostavax) administered by a GP or other healthcare provider whilst they were aged at least 70 years and less than 80 years of age.
  2. two doses of Shingrix administered whilst they were aged at least 70 years old but not yet 81 years old.

What will remove patients from eligibility?

  1. They have a contraindicated code before the end of the contract year

  2. They have had a shingles declined code added when they were at least 70 but not yet 80, with no subsequent shingles vaccination

  3. They received a first dose of shingles vaccine between age 70 and 80 and then chose not to receive a shingles vaccination before the end of the contract year

  4. If they had their first dose of shingles vaccination before 80, turned 80 in the contract year but haven't had their second dose (these will get picked up in the following year

If a patient achieves the indicator at any point during the year, any exclusions that have also been added are ignored.

Hints and tips for achieving this indicator

The PCIT searches can help you to identify patients that you need to action to achieve this indicator.  

SNOMED codes used in this indicator

The codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD).  Not all of these may be present or selectable in all clinical systems.

Codes for Shingles single dose vaccination (SHVACGP_COD)

SNOMED code

SNOMED code description

722215002

Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles

859641000000109
Herpes zoster vaccination
871898007
Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen
871899004
Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen via subcutaneous route

Codes for Shingles double dose first vaccination (SHVACGP1_COD)

SNOMED code

SNOMED code description

1326101000000105

Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles

Codes for Shingles double dose second vaccination (SHVACGP2_COD)

SNOMED code
SNOMED code description
1326111000000107
Administration of second dose of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles

Codes Shingles contraindication (SHCON_COD)

SNOMED code

SNOMED code description

868531000000103

Herpes zoster vaccination contraindicated

Codes indicating the patient chose not to receive a shingles vaccination (SHDEC_COD)

SNOMED code

SNOMED code description

723062007

Varicella zoster vaccination declined by patient

868551000000105Herpes zoster vaccination declined
9691000175102Herpes zoster vaccination declined


    • Related Articles

    • IIF VI-01 / VI-02 / VI-03

      VI-01 (NCD002) Percentage of patients aged 65 years or over, who received a seasonal influenza vaccination between 1 September and 31 March This indicator is looking at patients born before 1st April 1958. There are some exclusions for patients with ...

    • Respiratory Syncytial Virus (RSV) vaccination programme

      !!General holding information for RSV programme in anticipation of development work!! The new vaccination programme against Respiratory Syncytial Virus (RSV) begins on 1st September 2024. The virus is perhaps more commonly known about in young ...

    • General practice vaccination and immunisation services: standards and core contractual requirements

      The NHS England document this support article relates to was published on 15th April 2024 What do I need to know? Why has this been issued now Previously a letter issued on 10th March 2021 had laid out the V&I standards and core contractual ...

    • VI002 - 1st MMR given before 18 months of age

      The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). Indicator definition Indicator ID Description VI002 The percentage of children who reached 18 months old in the preceding ...

    • VI001 - DTP primary course completed before 8 months of age

      The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). Indicator definition Indicator ID Description VI001 The percentage of babies who reached 8 months old in the preceding 12 ...